May 19, 2011

Data at ASCO Showcase Sanofi’s Commitment to Research and Identify Treatments for Cancer Patients

Iniparib and Semuloparin Phase III Data Selected for Oral Presentation and Best of ASCO

 

Data at ASCO Showcase Sanofi’s Commitment to Research and Identify Treatments for Cancer Patients
Iniparib and Semuloparin Phase III Data Selected for Oral Presentation and Best of ASCO

Paris, France – May 19, 2011 – Sanofi (EURONEXT: SAN and NYSE: SNY) today announced that data from eight compounds in the company’s robust oncology portfolio will be showcased in more than 100 abstracts at the 47th Annual Meeting of the American Society of Clinical Oncology (ASCO) in Chicago, June 3-7, 2011.